Company Gilead Sciences, which manufactures the drug ramdevpir, recognized as effective for treating coronavirus infection, announced in an open letter that she decided to set the price at $390 per bottle for the U.S. government, reported CNN on June 29.
The five-day course of treatment for one patient will include six bottles and will cost $2340, said Daniel O’day, President and chief Executive officer of the company.
Price for private companies will be $520 for a bottle that will be $3120 per patient.
The drug from Ebola ramdevpir in the United States were allowed to apply to adults and children hospitalized with COVID-19, who are in serious condition.
Ramdevpir – the first medicinal product, which are allowed to apply in the European Union during coronavirus infection in adults and adolescents from 12 years of age.
Drug ramdevpir included in the Ukrainian Protocol of treatment of coronavirus infection COVID-19, said the Minister of health, Maxim Stepanov on April 19. The health Ministry wants to buy this medicine and take it back to Ukraine through diplomatic channels.
Flash coronavirus infection COVID-19 began in December 2019 in the Chinese city of Wuhan. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
According to data from the American Johns Hopkins University, aboutbsee number of infected people in the world reached almost 10.2 million, of which nearly cured of 5.17 million and 503 thousand died.